MPP Strikes Long-Acting Injectable Cabotegravir Deal For HIV PrEP

Prospective Sub-Licensees Have Until 4 September To Submit Expressions Of Interest

 
• By Dave Wallace
  
MPP Medicines Patent Pool Logo Hand Syringe
The MPP has secured a license for long-acting injectable cabotegravir • Source: Shutterstock

More from Deals

More from Business